Adocia | Evaluate

August 23, 2019

Adocia’s David comes unstuck against Lilly’s Goliath

January 08, 2018

Asia wins 2017’s mid-cap race

A cooling of the M&A climate allows Asia-based groups to come to the fore.

October 05, 2017

Back to the future for small caps, but not all benefit

Oncology-focused smaller biotechs reap rich rewards, but generics groups face hard times.

January 27, 2017

Snippet roundup: A bad week for Bristol and Adocia

December 23, 2016

Snippet roundup: Biogen's chief exec choice underwhelms as a big 2016 decision is delayed to 2017

August 26, 2016

Snippet roundup: Adocia fails, Nymox perseveres, FDA rejects Amgen and backs Impact

January 08, 2015

Buoyant small pharma market hides some big losers

December 19, 2014

$50m gift entices Adocia to take Lilly back

October 08, 2014

Interview – Adocia hopes ultrafast insulin will be a sweet target for partners

October 06, 2014

Acquisitions help define performance of mid and small cap stocks

February 21, 2013

Choice newcomers piggyback on 2012’s IPO successes

Load More